Concerted interactions between multiple gp41 trimers and the target cell lipidome may be required for HIV-1 entry

The HIV-1 envelope glycoprotein gp41 mediates the fusion between viral and host cell membranes leading to virus entry and target cell infection. Despite years of research, important aspects of this process such as the number of gp41 trimers involved and how they orchestrate the rearrangement of the lipids in the apposed membranes along the fusion pathway remain obscure. To elucidate these molecular underpinnings, we performed coarse-grained molecular dynamics simulations of HIV-1 virions pinned to the CD4 T cell membrane by different numbers of gp41 trimers. We built realistic cell and viral membranes by mimicking their respective lipid compositions. We found that a single gp41 was inadequate for mediating fusion. Lipid mixing between membranes, indicating the onset of fusion, was efficient when 3 or more gp41 trimers pinned the membranes. The gp41 trimers interacted strongly with many different lipids in the host cell membrane, triggering lipid configurational rearrangements, exchange, and mixing. Simpler membranes, comprising fewer lipid types, displayed strong resistance to fusion, revealing the crucial role of the lipidomes in HIV-1 entry. Performing simulations at different temperatures, we estimated the free energy barrier to lipid mixing, and hence membrane stalk formation, with 4 tethering gp41 trimers to be ~6.2 kcal/mol, a >4-fold reduction over estimates without gp41. Together, these findings present molecular-level, quantitative insights into the early stages of gp41-mediated HIV-1 entry. Preventing the requisite gp41 molecules from tethering the membranes or altering membrane lipid compositions may be potential intervention strategies. SIGNIFICANCE Interactions between viral envelope proteins and host cell surface receptors leading to HIV-1 entry are well studied, however the role of membrane lipids remains obscure, although entry hinges on lipid mixing and the fusion of viral and cell membranes. We performed detailed simulations of HIV-1 and target cell membranes tethered by viral gp41 trimeric proteins to elucidate the proteo-lipidic contributions to viral entry. We found that the cooperative effects of multiple gp41 trimers and natural lipidomes of the membranes facilitate membrane fusion. The functional domains of gp41 altered local lipid concentrations, reduced membrane repulsions, and facilitated inter-membrane lipid mixing. These molecular-level insights offer a glimpse of the cryptic mechanisms underlying HIV-1 entry and suggest new interventions to combat HIV-1 infection.

[1]  D. Graham,et al.  Lipid rafts and HIV pathogenesis: virion-associated cholesterol is required for fusion and infection of susceptible cells. , 2003, AIDS research and human retroviruses.

[2]  Siewert J Marrink,et al.  The mechanism of vesicle fusion as revealed by molecular dynamics simulations. , 2003, Journal of the American Chemical Society.

[3]  S. Harrison Mechanism of Membrane Fusion by Viral Envelope Proteins , 2005, Advances in Virus Research.

[4]  Huey W. Huang,et al.  Evidence of cholesterol accumulated in high curvature regions: implication to the curvature elastic energy for lipid mixtures. , 2007, Biophysical journal.

[5]  J. Enderlein,et al.  Envelope glycoprotein mobility on HIV-1 particles depends on the virus maturation state , 2017, Nature Communications.

[6]  Reinhard Lipowsky,et al.  Tension-induced fusion of bilayer membranes and vesicles , 2005, Nature materials.

[7]  Biswajit Gorai,et al.  Prediction and validation of HIV-1 gp41 ecto-transmembrane domain post-fusion trimeric structure using molecular modeling , 2020, Journal of biomolecular structure & dynamics.

[8]  Yonathan Kozlovsky,et al.  Stalk model of membrane fusion: solution of energy crisis. , 2002, Biophysical journal.

[9]  Volker Knecht,et al.  Molecular dynamics simulations of lipid vesicle fusion in atomic detail. , 2007, Biophysical journal.

[10]  Taehoon Kim,et al.  CHARMM‐GUI: A web‐based graphical user interface for CHARMM , 2008, J. Comput. Chem..

[11]  Helgi I Ingólfsson,et al.  CHARMM-GUI Martini Maker for Coarse-Grained Simulations with the Martini Force Field. , 2015, Journal of chemical theory and computation.

[12]  D. van der Spoel,et al.  GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .

[13]  Hans-Georg Kräusslich,et al.  The HIV lipidome: a raft with an unusual composition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Lifson,et al.  Distribution and three-dimensional structure of AIDS virus envelope spikes , 2006, Nature.

[15]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[16]  Annick Thomas,et al.  Hydrophobic substitutions in the first residue of the CRAC segment of the gp41 protein of HIV. , 2008, Biochemistry.

[17]  B. O’Shaughnessy,et al.  SNARE‐mediated membrane fusion is a two‐stage process driven by entropic forces , 2018, FEBS letters.

[18]  F. Jensen,et al.  Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Eric Hunter,et al.  Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry , 1998, Nature Medicine.

[20]  M. Klein,et al.  Effective interaction between small unilamellar vesicles as probed by coarse-grained molecular dynamics simulations , 2014 .

[21]  Judith M. White,et al.  HIV gp41-Mediated Membrane Fusion Occurs at Edges of Cholesterol-Rich Lipid Domains , 2015, Nature chemical biology.

[22]  Reinhard Lipowsky,et al.  Solvent-exposed tails as prestalk transition states for membrane fusion at low hydration. , 2010, Journal of the American Chemical Society.

[23]  S. Durell,et al.  HIV Entry and Envelope Glycoprotein-mediated Fusion* , 2012, The Journal of Biological Chemistry.

[24]  Baoshan Zhang,et al.  Broad and potent neutralization of HIV-1 by a gp41-specific human antibody , 2012, Nature.

[25]  I. Vattulainen,et al.  Multiscale Simulations of Biological Membranes: The Challenge To Understand Biological Phenomena in a Living Substance , 2019, Chemical reviews.

[26]  Craig B Wilen,et al.  HIV: cell binding and entry. , 2012, Cold Spring Harbor perspectives in medicine.

[27]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[28]  A. Trkola,et al.  Different Infectivity of HIV-1 Strains Is Linked to Number of Envelope Trimers Required for Entry , 2015, PLoS pathogens.

[29]  M. Klein,et al.  Coarse-grained molecular dynamics study of membrane fusion: Curvature effects on free energy barriers along the stalk mechanism. , 2015, The Journal of chemical physics.

[30]  A. Trkola,et al.  The HIV-1 Entry Process: A Stoichiometric View. , 2015, Trends in microbiology.

[31]  G. Sapiro,et al.  Molecular architecture of native HIV-1 gp120 trimers , 2008, Nature.

[32]  I. Wilson,et al.  Insights into the trimeric HIV-1 envelope glycoprotein structure. , 2015, Trends in biochemical sciences.

[33]  W F Drew Bennett,et al.  Improved Parameters for the Martini Coarse-Grained Protein Force Field. , 2013, Journal of chemical theory and computation.

[34]  Felix Sedlmeier,et al.  Hydration repulsion between biomembranes results from an interplay of dehydration and depolarization , 2012, Proceedings of the National Academy of Sciences.

[35]  G. Melikyan Membrane fusion mediated by human immunodeficiency virus envelope glycoprotein. , 2011, Current topics in membranes.

[36]  Dennis R Burton,et al.  Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design. , 2016, Annual review of immunology.

[37]  Sriram Subramaniam,et al.  Electron Tomography of the Contact between T Cells and SIV/HIV-1: Implications for Viral Entry , 2007, PLoS pathogens.

[38]  F. Jensen,et al.  Lipid composition and fluidity of the human immunodeficiency virus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[39]  David A. Price,et al.  Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity , 2005, Antimicrobial Agents and Chemotherapy.

[40]  M. Gochin,et al.  Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor design. , 2011, Current topics in medicinal chemistry.